Substance Abuse and Mental Health Services Administration. (2021) Medications for opioid use disorder. Rockville, MD: Substance Abuse and Mental Health Services Administration. Treatment Improvement Protocol (TIP) series 63 publication no. PEP21-02-01-002.
Preview | Title | Contact |
---|---|---|
|
PDF (TIP 63: Medications for opioid use disorder)
3MB | |
|
PDF (TIP 63: Medications for opioid use disorder - Executive summary)
1MB |
External website: https://store.samhsa.gov/product/SMA18-5063FULLDOC
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
Audience: people with substance use or abuse problems as audience, public health professionals, professional care providers, policymakers, family & advocates, parents & caregivers.
Executive Summary
For healthcare and addiction professionals, policymakers, patients, and families
Part 1: Introduction to Medications for Opioid Use Disorder Treatment
For healthcare and addiction professionals, policymakers, patients, and families
Part 2: Addressing Opioid Use Disorder in General Medical Settings
For healthcare professionals
Part 3: Medications for Opioid Use Disorder
For healthcare professionals
Part 4: Bringing Together Addiction Treatment Counselors, Clients, and Healthcare Professionals
For healthcare and addiction professionals
Part 5: Resources Related to Medications for Opioid Use Disorder
For healthcare and addiction professionals, policymakers, patients, and families
B Substances > Opioids (opiates) > Opioid product > Naltrexone
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
B Substances > Opioids (opiates) > Opioid product > Methadone
E Concepts in biomedical areas > Medical substance > Prescription drug (medicine / medication)
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and rehabilitation > Patient / client care management
J Health care, prevention, harm reduction and rehabilitation > Treatment and maintenance > Treatment factors
VA Geographic area > United States
Repository Staff Only: item control page